Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels

Details for Australian Patent Application No. 2003213259 (hide)

International Classifications

Event Publications

24 July 2003 Complete Application Filed

Priority application(s): 60/358,382 22.02.02 US; 60/362,083 07.03.02 US

16 October 2003 Application Open to Public Inspection

Published as AU-B-2003213259

23 October 2003 Application Open to Public Inspection

Published as AU-B-2003213259

24 January 2008 Assignment before Grant

New River Pharmaceuticals Inc. The application has been assigned to Shire LLC

8 January 2009 Application Accepted

Published as AU-B-2003213259

26 March 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 30 Jan 2009. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000

16 July 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 30 Jan 2009

23 July 2009 Standard Patent Sealed

22 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.